SARAH LINDSAY: Open Payments
NPI 1265883201 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 26 payments from 14 companies in 2025. Trend: 2023 $524 · 2024 $712 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 5 | $175 |
| Novo Nordisk Inc | 2 | $138 |
| Edwards Lifesciences Corporation | 1 | $120 |
| Alnylam Pharmaceuticals Inc. | 4 | $117 |
| Medtronic, Inc. | 2 | $55 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Abbott Laboratories | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: FUROSCIX, Wegovy, ONPATTRO, ELIQUIS, SYMPLICITY G3, NEXLETOL, VERQUVO, CARDIOMEMS.
Industry payments across LA — which companies pay providers there.
